Home |
Free Dividend Report |
Stock Splits Calendar |
TCON Historical Stock Prices |
Preferred Stock Newsletter |
TCON Options Chain |
Stock Message Boards |
TRACON Pharmaceuticals (TCON) has the following price history information. Looking back at TCON historical stock prices for the last five trading days, on March 22, 2024, TCON opened at $0.45, traded as high as $0.55 and as low as $0.45, and closed at $0.46. Trading volume was a total of 10.16M shares. On March 25, 2024, TCON opened at $0.47, traded as high as $0.50 and as low as $0.44, and closed at $0.46. Trading volume was a total of 3.71M shares. On March 26, 2024, TCON opened at $0.46, traded as high as $0.46 and as low as $0.39, and closed at $0.43. Trading volume was a total of 3.38M shares. On March 27, 2024, TCON opened at $0.41, traded as high as $0.43 and as low as $0.39, and closed at $0.41. Trading volume was a total of 1.60M shares. On March 28, 2024, TCON opened at $0.41, traded as high as $0.46 and as low as $0.40, and closed at $0.43. Trading volume was a total of 3.11M shares.
TCON Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into TRACON Pharmaceuticals shares, starting with a $10,000 purchase of TCON, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 02/02/2015 | |
End date: | 03/28/2024 | |
Start price/share: | $95.00 | |
End price/share: | $0.43 | |
Dividends collected/share: | $0.00 | |
Total return: | -99.55% | |
Average Annual Total Return: | -44.55% | |
Starting investment: | $10,000.00 | |
Ending investment: | $45.27 | |
Years: | 9.15 |
TCON Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
03/22/2024 | $0.45 | $0.55 | $0.45 | $0.46 | 10.16M |
03/25/2024 | $0.47 | $0.50 | $0.44 | $0.46 | 3.71M |
03/26/2024 | $0.46 | $0.46 | $0.39 | $0.43 | 3.38M |
03/27/2024 | $0.41 | $0.43 | $0.39 | $0.41 | 1.60M |
03/28/2024 | $0.41 | $0.46 | $0.40 | $0.43 | 3.11M |
About TRACON Pharmaceuticals |
TRACON Pharmaceuticals is a biopharmaceutical company. Co. has a collaboration and clinical trial agreement for the development of envafolimab, an investigational PD-L1 single-domain antibody for the treatment of sarcoma in North America. Co.'s other clinical stage oncology product candidates include YH001, which is a monospecific investigational cytotoxic T-lymphocyte-associated protein 4 antibody, TRC102, which is a small molecule that has been studied in Phase 1 and Phase 2 trials for the treatment of mesothelioma, lung cancer, glioblastoma and solid tumors, and TJ004309, which is a CD73 antibody in Phase 1 clinical development for the treatment of solid tumors. |
TCON Historical Closing Prices | |
Date | Close |
03/22/2024 | $0.46 |
03/25/2024 | $0.46 |
03/26/2024 | $0.43 |
03/27/2024 | $0.41 |
03/28/2024 | $0.43 |
Healthcare Historical Prices |
TCON is categorized under the Healthcare sector; below are some other companies in the same sector:
TDOC Historical Stock Prices Also explore: TCON shares outstanding history
Free TCON Email Alerts:
|
TCON Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.